VistaGen Therapeutics
VTGN
#8994
Rank
S$0.10 B
Marketcap
$3.66
Share price
-3.19%
Change (1 day)
-14.70%
Change (1 year)

VistaGen Therapeutics (VTGN) - P/B ratio

P/B ratio as of November 2024 : 0.7253

According to VistaGen Therapeutics 's latest financial reports the company has a price-to-book ratio of 78.3314.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

VistaGen Therapeutics - P/B ratio (from 2011 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-311.139.33%
2022-12-311.03-78.84%
2021-12-314.8771.66%
2020-12-312.84-157.99%
2019-12-31-4.89-117.77%
2018-12-3127.51061%
2017-12-312.37-80.37%
2016-12-3112.1-207.2%
2015-12-31-11.31678.23%
2014-12-31-0.6334-22.06%
2013-12-31-0.8127-39.47%
2012-12-31-1.34-86.96%
2011-12-31-10.3
2010-12-31N/A
2009-12-31N/A
2008-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.06 184.10%๐Ÿ‡บ๐Ÿ‡ธ USA